tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amneal Pharmaceuticals reports Q3 adjusted EPS 17c, consensus 14c
PremiumThe FlyAmneal Pharmaceuticals reports Q3 adjusted EPS 17c, consensus 14c
28d ago
Amneal Pharmaceuticals raises 2025 adjusted EPS view to 75c-80c from 70c-75c
Premium
The Fly
Amneal Pharmaceuticals raises 2025 adjusted EPS view to 75c-80c from 70c-75c
28d ago
Amneal gets FDA approval for beclomethasone dipropionate HFA inhalation aerosol
Premium
The Fly
Amneal gets FDA approval for beclomethasone dipropionate HFA inhalation aerosol
28d ago
Amneal Pharmaceuticals announces submission of BLA to U.S. FDA for XOLAIR
PremiumThe FlyAmneal Pharmaceuticals announces submission of BLA to U.S. FDA for XOLAIR
2M ago
Amneal Pharmaceuticals Positioned for Significant Growth with Strong Product Momentum and Strategic Advantages
Premium
Ratings
Amneal Pharmaceuticals Positioned for Significant Growth with Strong Product Momentum and Strategic Advantages
2M ago
Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution
Premium
The Fly
Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution
2M ago
Amneal Pharma’s Optimistic Q2 Earnings Call Highlights
PremiumCompany AnnouncementsAmneal Pharma’s Optimistic Q2 Earnings Call Highlights
4M ago
Knight Therapeutics announces CREXONT regulatory submission in Mexico
Premium
The Fly
Knight Therapeutics announces CREXONT regulatory submission in Mexico
4M ago
Amneal Pharmaceuticals Reports Strong Q2 2025 Results
Premium
Company Announcements
Amneal Pharmaceuticals Reports Strong Q2 2025 Results
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100